Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | 10-K | mrk-20231231.htm iXBRL | 10-K | 5080817 |
| 2 | EX-10.7 FORM OF STOCK OPTION TERMS FOR 2017 ANNUAL NON-QUALIFIED OPTION GRANTS | ex107-2017annualnqsotermsc.htm | EX-10.7 | 34962 |
| 3 | EX-10.8 FORM OF STOCK OPTION TERMS FOR 2019 ANNUAL NON-QUALIFIED OPTION GRANTS | ex108-2019annualnqsotermsa.htm | EX-10.8 | 43881 |
| 4 | EX-10.13 MERCK & CO., INC. U.S. SEPARATION BENEFITS PLAN | ex1013-plansepmrk2019.htm | EX-10.13 | 503445 |
| 5 | EX-10.21 2020 ANNUAL NQSO TERMS AND CONDITIONS | ex1021-2020annualnqsoterms.htm | EX-10.21 | 41031 |
| 6 | EX-10.22 2020 ANNUAL RSU TERMS AND CONDITIONS | ex1022-2020annualrsutermsa.htm | EX-10.22 | 41590 |
| 7 | EX-10.23 2021 ANNUAL PSU TERMS AND CONDITIONS | ex1023-2021annualpsuterms.htm | EX-10.23 | 80592 |
| 8 | EX-10.24 2021 RSU GRANT TERMS UNDER MERCK CO INC 2019 ISP | ex1024-2021specialretentio.htm | EX-10.24 | 40187 |
| 9 | EX-10.25 2022 ANNUAL RSU TERMS AND CONDITIONS | ex1025-2022annualrsutermsa.htm | EX-10.25 | 320481 |
| 10 | EX-10.26 2022 ANNUAL PSU TERMS AND CONDITIONS AUGUST (GUINDO) | ex1026-2022annualpsutermsa.htm | EX-10.26 | 196248 |
| 11 | EX-10.27 2023 ANNUAL NQSO TERMS AND CONDITIONS | ex1027-2023annualnqsoterms.htm | EX-10.27 | 152265 |
| 12 | EX-10.28 2022 ANNUAL PSU TERMS AND CONDITIONS | ex1028-2022annualpsutermsa.htm | EX-10.28 | 100770 |
| 13 | EX-10.29 2023 ANNUAL PSU TERMS AND CONDITIONS | ex1029-2023annualpsutermsa.htm | EX-10.29 | 189567 |
| 14 | EX-10.30 OFFER LETTER (GUINDO) | ex1030-mrkchirfiguindooffe.htm | EX-10.30 | 47370 |
| 15 | EX-21 SUBSIDIARY LIST | ex21-subsidiarylistasof123.htm | EX-21 | 312516 |
| 16 | EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ex23-consentofindependentr.htm | EX-23 | 2323 |
| 17 | EX-24.1 POWER OF ATTORNEY | ex241-powerofattorney.htm | EX-24.1 | 14715 |
| 18 | EX-24.2 CERTIFICATION OF BOARD RESOLUTION | ex242-certificationofboard.htm | EX-24.2 | 6759 |
| 19 | EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | ex311-rule13ax14a15dx14ace.htm | EX-31.1 | 8068 |
| 20 | EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | ex312-rule13ax14a15dx14ace.htm | EX-31.2 | 8103 |
| 21 | EX-32.1 SECTION 1350 CERTIFICATION OF CEO | ex321-section1350certifica.htm | EX-32.1 | 4057 |
| 22 | EX-32.2 SECTION 1350 CERTIFICATION OF CFO | ex322-section1350certifica.htm | EX-32.2 | 3662 |
| 23 | EX-97 MERCK RECOUPMENT POLICY | ex97-merckrecoupmentpolicy.htm | EX-97 | 19562 |
| 29 | mrk-20231231_g1.jpg | GRAPHIC | 137767 | |
| 30 | mrk-20231231_g2.jpg | GRAPHIC | 82583 | |
| 31 | mrk-20231231_g3.jpg | GRAPHIC | 28277 | |
| 32 | mrk-20231231_g4.jpg | GRAPHIC | 24891 | |
| 33 | mrk-20231231_g5.jpg | GRAPHIC | 24379 | |
| 34 | mrk-20231231_g6.jpg | GRAPHIC | 25771 | |
| 35 | mrk-20231231_g7.gif | GRAPHIC | 5605 | |
| 36 | mrk-20231231_g8.jpg | GRAPHIC | 31485 | |
| 37 | mrk-20231231_g9.jpg | GRAPHIC | 17845 | |
| Complete submission text file | 0001628280-24-006850.txt | 29075527 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 24 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20231231.xsd | EX-101.SCH | 126440 |
| 25 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20231231_cal.xml | EX-101.CAL | 192302 |
| 26 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20231231_def.xml | EX-101.DEF | 800944 |
| 27 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20231231_lab.xml | EX-101.LAB | 1659744 |
| 28 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20231231_pre.xml | EX-101.PRE | 1172170 |
| 164 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20231231_htm.xml | XML | 5809835 |
EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 24678716
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)
